PIGA, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 331.969
NA - Nord America 10.351
AS - Asia 4.617
SA - Sud America 917
AF - Africa 128
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 348.005
Nazione #
IT - Italia 329.441
US - Stati Uniti d'America 10.164
SG - Singapore 1.881
CN - Cina 1.550
BR - Brasile 711
SE - Svezia 617
DE - Germania 455
UA - Ucraina 416
VN - Vietnam 393
FI - Finlandia 254
GB - Regno Unito 235
FR - Francia 123
CA - Canada 110
KR - Corea 102
IN - India 93
NL - Olanda 93
HK - Hong Kong 87
JP - Giappone 79
AR - Argentina 73
IQ - Iraq 64
BD - Bangladesh 53
RU - Federazione Russa 52
TR - Turchia 51
ES - Italia 47
MX - Messico 44
ID - Indonesia 41
AT - Austria 40
EC - Ecuador 38
IR - Iran 37
PL - Polonia 37
IL - Israele 34
EG - Egitto 30
ZA - Sudafrica 27
BE - Belgio 26
CO - Colombia 23
MA - Marocco 23
SA - Arabia Saudita 21
CH - Svizzera 19
GR - Grecia 19
PE - Perù 19
AU - Australia 18
PK - Pakistan 18
RO - Romania 14
CL - Cile 13
CZ - Repubblica Ceca 13
UZ - Uzbekistan 13
BO - Bolivia 12
IE - Irlanda 12
TN - Tunisia 12
PH - Filippine 11
TW - Taiwan 11
JO - Giordania 10
UY - Uruguay 10
VE - Venezuela 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
DZ - Algeria 7
AZ - Azerbaigian 6
GT - Guatemala 6
KE - Kenya 6
PY - Paraguay 6
RS - Serbia 6
TH - Thailandia 6
CY - Cipro 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
KG - Kirghizistan 5
NO - Norvegia 5
PA - Panama 5
PS - Palestinian Territory 5
AL - Albania 4
BH - Bahrain 4
BY - Bielorussia 4
LK - Sri Lanka 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
PT - Portogallo 4
SN - Senegal 4
BG - Bulgaria 3
GH - Ghana 3
JM - Giamaica 3
KZ - Kazakistan 3
MU - Mauritius 3
NP - Nepal 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
CU - Cuba 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
QA - Qatar 2
A1 - Anonimo 1
AM - Armenia 1
Totale 347.983
Città #
Cagliari 206.504
Uta 122.156
Dallas 1.321
Fairfield 1.016
Ashburn 935
Singapore 779
Woodbridge 696
Houston 552
Boardman 532
Chandler 430
Wilmington 404
Nyköping 394
Seattle 369
Ann Arbor 359
Beijing 342
Cambridge 339
Jacksonville 218
Los Angeles 204
Dearborn 179
Munich 167
Shanghai 161
Santa Clara 152
Hefei 151
Dong Ket 144
Helsinki 144
Boston 135
Buffalo 103
New York 97
Ho Chi Minh City 91
Seoul 89
Nanjing 86
Rome 83
The Dalles 81
Redwood City 71
Hong Kong 68
Chicago 65
San Diego 58
Milan 57
São Paulo 56
Amsterdam 52
Tokyo 50
London 47
Hanoi 46
Redondo Beach 42
Nuremberg 41
Toronto 41
Nanchang 38
Phoenix 38
Baghdad 37
Guangzhou 34
Shenyang 31
Council Bluffs 30
Columbus 29
Lappeenranta 28
Salt Lake City 28
Tianjin 28
Changsha 27
Washington 27
Mountain View 26
Belo Horizonte 25
Warsaw 25
Brooklyn 24
Selargius 23
Vienna 22
Guayaquil 21
Hebei 21
Montreal 21
Paris 21
Atlanta 20
Brussels 19
Frankfurt am Main 19
Rio de Janeiro 19
Buenos Aires 18
San Mateo 18
Stockholm 17
Turku 17
Dhaka 16
Düsseldorf 16
Norwalk 16
Orem 16
Sassari 16
Denver 15
Elk Grove Village 15
Jiaxing 15
Lauterbourg 15
Mexico City 15
Orange 15
Cairo 14
Johannesburg 14
Bat Yam 13
Brasília 13
Kunming 13
Madrid 13
Mumbai 13
San Francisco 13
Wuhan 13
Casablanca 12
Diyarbakır 12
Hangzhou 12
Manchester 12
Totale 341.195
Nome #
Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology 118.777
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.715
Overexpression of the cytokine BAFF and autoimmunity risk 4.057
An optimized infrastructure for deferred telemonitoring of home rehabilitation in chronic rheumatic patients 3.910
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.132
Home tele-rehabilitation for rheumatic patients: impact and satisfaction of care analysis 3.074
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.029
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.006
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 2.989
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.878
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.794
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.778
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.765
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.604
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.573
A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients 2.564
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.328
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.309
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.306
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.263
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.259
null 2.245
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.225
Polymyalgia rheumatica: an autoinflammatory disorder? 2.218
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 2.188
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.163
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.162
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.131
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.130
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.101
An Integrated Portable Device for the Hand Functional Assessment in the Clinical Practice 2.075
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.073
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation? 2.051
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.049
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 1.999
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.961
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.928
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.927
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.903
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.899
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.899
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 1.819
null 1.791
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.756
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.666
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.598
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 1.589
Validità di un dispositivo portatile (Re.Mo.To.) per la valutazione della disabilità della mano in pazienti affetti da malattie reumatiche sistemiche 1.587
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.573
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 1.570
null 1.562
How Do Patients with Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria 1.515
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.515
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 1.470
Nonlinear model for the carotid artery disease 10-year risk prediction by fusing conventional cardiovascular factors to carotid ultrasound image phenotypes: A Japanese diabetes cohort study 1.469
Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning–Based Tissue Characterization 1.454
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 1.448
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.440
null 1.431
Genetics of Behcet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients 1.427
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.424
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.417
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography 1.395
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 1.388
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 1.372
Effect of carotid image-based phenotypes on cardiovascular risk calculator: AECRS1.0 1.371
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.347
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 1.332
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes 1.306
Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy 1.283
Telerehabilitation of the hand: the Re.Mo.To. project experience 1.270
null 1.241
Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study 1.230
Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting 1.175
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients 1.159
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.124
Targeted Therapies in Axial Psoriatic Arthritis 1.119
null 1.111
Physician global assessment in systemic lupus erythematosus: Can we rely on its reliability? 1.110
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.099
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort 1.065
Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease 1.059
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 1.050
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.036
The origin of Behçet’s disease geoepidemiology: possible role of a dual microbial - driven genetic selection. 1.034
Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis 1.014
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.010
Ultrasonography in psoriatic arthritis: Which sites should we scan? 1.006
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.004
Methotrexate and vasculoprotection: Mechanistic insights and potential therapeutic applications in old age 1.002
Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus 984
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 982
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 975
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 960
Repurposing existing drugs for cardiovascular risk management: A focus on methotrexate 916
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 906
null 902
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 899
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 891
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 879
Totale 298.964
Categoria #
all - tutte 415.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 415.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.304 0 0 0 0 0 4.900 3.547 2.399 1.033 1.961 2.056 1.408
2021/202211.988 1.096 773 613 615 957 874 659 705 1.330 1.153 1.785 1.428
2022/202317.251 1.658 2.324 2.026 1.295 1.498 1.758 907 1.341 1.183 1.156 1.305 800
2023/202430.203 1.058 842 815 1.604 2.155 3.466 3.169 9.882 1.221 1.285 2.565 2.141
2024/2025172.060 14.239 15.934 8.407 121.836 3.075 2.912 3.224 263 550 446 579 595
2025/20266.618 796 874 1.794 1.218 1.092 844 0 0 0 0 0 0
Totale 348.956